This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Jun;57(6):563-4; author reply 564.

doi: 10.1136/thorax.57.6.563-a.

Pathophysiology of COPD

M Kelly

PMID: 12037238
PMCID: PMC1746357
DOI: 10.1136/thorax.57.6.563-a

Comment

Pathophysiology of COPD

M Kelly. Thorax. 2002 Jun.

. 2002 Jun;57(6):563-4; author reply 564.

doi: 10.1136/thorax.57.6.563-a.

Author

M Kelly

PMID: 12037238
PMCID: PMC1746357
DOI: 10.1136/thorax.57.6.563-a

No abstract available

PubMed Disclaimer

Comment on

Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.
Dentener MA, Creutzberg EC, Schols AM, Mantovani A, van't Veer C, Buurman WA, Wouters EF. Dentener MA, et al. Thorax. 2001 Sep;56(9):721-6. doi: 10.1136/thorax.56.9.721. Thorax. 2001. PMID: 11514694 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information